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Abstract 9 
 10 
 11 
 Human life histories are shaped by the allocation of metabolic energy to 12 
competing physiological domains.  A model framework of the pathways of energy 13 
allocation is described and hormonal regulators of allocation along the pathways of the 14 
framework are discussed in the light of evidence from field studies of the endocrinology 15 
of human energetics.  The framework is then used to generate simple models of two 16 
important life history transitions in humans, puberty and the postpartum return to full 17 
fecundity in females.  The results of the models correspond very closely to observations 18 
made in the field. 19 
 20 
 21 
 22 
Introduction 23 
 24 
 The essence of life can be defined as “metabolism in the service of 25 
reproduction.”  Organisms capture energy from the environment and turn it into more 26 
organisms.  Natural selection has favored those variations that perform this task more 27 
reliably and more efficiently than their competitors.  But the route from energy capture to 28 
reproduction can be complex.  Even in the simplest organisms some captured energy 29 
must be devoted to growth and maintenance of the organism as well as to reproduction.  30 
Reproduction without growth would rapidly lead to smaller and smaller organisms until 31 
the size limits of viability were reached.  Investment in maintenance leads to increased 32 
survivorship and opportunities to continue reproducing.  The partitioning of available 33 
energy among these non-overlapping categories gives rise to the patterning of life 34 
histories -- variation in age-specific probabilities of mortality and fertility, trajectories of 35 
growth, rates of senescence, and other aspects of phenotype that are only manifest in a 36 
diachronic view, in the way an organism’s life unfolds rather than in its state at any 37 
given time.   38 
 39 
 Life history theory emphasizes trade-offs and how optimal energy allocation 40 
varies with age and environmental circumstances.  But this body of theory often leaves 41 
unspecified the physiological mechanisms that govern and regulate those trade-offs.  42 
The field of human reproductive ecology has emerged out of an effort to understand 43 
those mechanisms as they relate to the regulation of reproductive effort in particular 44 
(Ellison, 2003a, 2009).  More recent efforts to illuminate the mechanisms governing 45 
trade-offs of investment in growth and immune function are helping to further advance 46 
an integration of the physiological mechanisms of energy allocation decisions with the 47 
conceptual framework of life history theory (Flatt and Heyland, 2011).  The focus of this 48 
paper will be a consideration of the ways the endocrine system helps to regulate 49 
metabolic energy allocation to generate the structure of human life history. 50 
 51 
 The endocrine system is one of the three major systems of integration of 52 
vertebrate physiology based on molecular communication, the other two being the 53 
nervous system and the immune system.  The power of the endocrine system as a 54 
physiological integrator lies in two properties: (i) the diffuse nature of its communication, 55 
reaching all cells of the organism, and (ii) its ability to regulate both cellular activity and 56 
gene expression.  Together these properties position the endocrine system to regulate 57 
energy allocation in ways that integrate with developmental and life history changes.   58 
 59 
 There are, however, two frequent biases in endocrinology that we should be 60 
particularly aware of in considering the regulation of metabolic energy allocation: the 61 
“top down bias” and the “newcomer bias.”  The top down bias is manifest in a 62 
predilection for assuming that the brain is in charge of the body.  In many areas this is 63 
true, but it is not an absolute hierarchy of regulation.  Elsewhere (Ellison, 2009) I have 64 
noted that molecular communication can be classified by the channels through which it 65 
flows into (a) central-nervous-system (CNS)-to-soma, (b) soma-to-CNS, (c) soma-to-66 
soma, and, (d) CNS-to-CNS.  Behavioral endocrinology is dominated by soma-to-CNS 67 
communication, coordinating behavior with the physiological state of the organism, 68 
particularly as regards the regulation of reproductive effort.  The most potent 69 
messengers along this pathway are those that easily cross the blood-brain barrier, 70 
especially steroids, as well as peptides that gain access to the basal hypothalamus.  71 
CNS-to-soma communication primarily flows through the hypothalamic-pituitary 72 
“transducer”, integrating sensory and other information from basal ganglia and higher 73 
cortical areas in the regulation of peripheral organs and endocrine glands.  Larger 74 
protein molecules are typical messengers along this pathway.  Both the soma-to-CNS 75 
and CNS-to-soma channels can have important effects on the allocation of metabolic 76 
energy.  But the primary conduit for messages regulating energy allocation is the soma-77 
to-soma channel.  This pathway includes messengers of all chemical types, including 78 
steroids (both gonadal and adrenal), thyroid hormones, proteins (including pancreatic 79 
hormones), and peptides (including gut hormones and adipokines).  In large part, as will 80 
be described, the action of messages flowing through the CNS-to-soma pathway on 81 
energy allocation is achieved by modifying the action of messages in the soma-to-soma 82 
pathway. 83 
 84 
 The newcomer bias is manifested in a natural fascination with newly discovered 85 
or described messenger molecules and the desire to see them as particularly important 86 
in their effects.  This can often be the case, but should not cause us to neglect the 87 
central roles that are often played by those messengers who have long featured in our 88 
understanding of endocrine physiology.  Many of these, such as steroids, thyroid 89 
hormones, pancreatic and gut hormones, also feature prominently in the soma-to-soma 90 
channel. 91 
 92 
 Keeping these biases in mind, we can consider the major features of the 93 
endocrine regulation of energy allocation decisions and their impact on human life 94 
history.  The framework described here will necessarily be an over-simplification, like all 95 
models.  Yet hopefully it will capture enough of the important features of the system to 96 
be heuristic, in organizing and synthesizing information, in illuminating complex 97 
interactions and processes, and in generating hypotheses.  Where possible, we will pay 98 
attention to evidence from and applications to field studies of human physiology. 99 
 100 
The endocrine framework of human energetics 101 
 102 
 The basic framework of human energetics, the flow of energy through the 103 
organism, is represented by the diagram in Figure 1 where the pathways indicated by 104 
specific arrows are associated with the hormonal regulators shown in Figure 2.  As a 105 
model, not all the pathways of physiological integration and regulation that affect 106 
energetics are included, nor all the potential endocrine signals involved.  Those that are 107 
included are considered to be major pathways and regulators which account for major 108 
aspects of energy allocation and its life history effects. 109 
 110 
 At the center of the framework is “available metabolic energy,” available for 111 
immediate allocation to any one of a number of non-overlapping categories.  Inputs to 112 
available metabolic energy come either from direct intake, or from stores, filtered by the 113 
regulation of ATP production.  The major allocation categories for available metabolic 114 
energy are identified as storage, activity, anabolism, and maintenance.  Anabolic sub-115 
categories include growth and reproduction.  The parts of this framework will be 116 
considered in turn. 117 
 118 
 119 
Regulation of energy balance 120 
 121 
 Energy balance refers to the difference between energy intake through nutrition 122 
and energy expenditure through all metabolic pathways.  Of the various pathways of 123 
energy expenditure, physical activity can be separated out as distinct from those that 124 
contribute to resting metabolic rate.  The net of energy intake and expenditure in activity 125 
can be considered as the contribution to available metabolic energy from the 126 
environment. 127 
 128 
 Energy intake is not tightly regulated by the endocrine system, since it depends 129 
greatly on environmental factors.  Appetite regulation, however, is strongly affected by 130 
endocrine signals (Badman and Flier, 2005; Blundell et al., 2015a; Blundell et al., 131 
2015b; Crespo et al., 2014; Meier and Gressner, 2004; Schwartz, 2000; Schwartz et al., 132 
2000; Webber et al., 2015).  Two signaling molecules that will be considered in this 133 
model are leptin and ghrelin.  Both are peptides, principally produced in the soma but 134 
capable of some penetration of the blood-brain barrier.  Leptin is primarily produced by 135 
adipocytes, ghrelin by the gut.  Both carry information to the hypothalamus that can 136 
affect appetite.  Leptin, a tonic hormone reflecting the mass of adipocytes, is associated 137 
with reduced hunger when circulating levels are high and increased hunger when levels 138 
are low (Schwartz et al., 2000).  Ghrelin, an episodic hormone which reflects short-term 139 
status of gut contents, with high levels occurring when the gut is relatively empty for an 140 
extended period, stimulates hunger when its levels are high (Pinkney, 2014).  These 141 
orexigenic effects are mediated by and coordinated with other neural signaling, primarily 142 
in the ventromedial hypothalamus (Webber et al., 2015).  143 
 144 
 Energy expenditure in activity is not under tight hormonal control in humans, but 145 
in rodent models, lowered leptin levels were early observed to correlate with increased 146 
levels of physical activity, perhaps reflecting a stimulation of the motivation to forage for 147 
food (Pelleymounter et al., 1995; Wolf, 1996).  In many rodents, food foraging exposes 148 
the animal to significant predation risk.  Appetite regulation may serve to help regulate 149 
foraging effort in a way that balances risks versus benefits.  There is no evidence at this 150 
time that foraging effort in human hunter-gatherer societies (the evolutionarily salient 151 
human subsistence pattern) or any other ecological context is related to hormonal 152 
appetite regulation.  However, there is clinical evidence that exercise may affect 153 
appetite through the mediation of appetite regulating hormones (Blundell et al., 2015b). 154 
 155 
 Studies of human leptin and ghrelin levels in the field have produced some 156 
notable results, particularly highlighting population variation in average levels 157 
(Bribiescas, 2001, 2005; Bribiescas and Hickey, 2006; Kuzawa et al., 2007; Miller et al., 158 
2006; Munch-Andersen et al., 2013; Sharrock et al., 2008; Tanaka et al., 2005).  In 159 
general, subjects in non-western populations and populations engaged in subsistence 160 
economies have significantly lower levels of both appetite regulating hormones than in 161 
western, developed societies.  This is true for leptin even after correcting for fat mass.  162 
At the least this suggests that caution needs to be exercised in interpreting the 163 
significance of absolute levels of these hormones.  It is likely that the set-points for 164 
appetite regulation may be influenced by developmental factors (Sharrock et al., 2008) 165 
and may reflect population differences in overall energy budgets. 166 
 167 
 168 
Regulation of energy availability 169 
 170 
 a. Release of oxidizable substrates 171 
 172 
 Oxidizable substrates (principally carbohydrates and fatty acids) are released 173 
from stores into the blood stream under the regulation of several different hormones.  174 
Among the most important regulators of energy substrate release in humans are 175 
cortisol, epinephrine, and glucagon.  Epinephrine and glucagon are relatively short-term 176 
regulators, involved in defending blood sugar homeostasis against the vagaries of 177 
intake and expenditure on a time scale of minutes to hours.  Because of their short-term 178 
effects, these hormones are often involved in behavioral responses, including “fight or 179 
flight” scenarios.  However, they are not directly implicated in the longer term regulation 180 
of energy substrate release that is typically involved in life history strategies and 181 
transitions. 182 
 183 
 Cortisol, on the other hand, is involved in longer term regulation of energy 184 
substrate availability.  Cortisol has been associated with responses to psychosocial 185 
stress, to the extent that it is frequently referred to as a “stress” hormone.  However, it 186 
can be misleading to label cortisol in this way, since psychosocial stress is only one 187 
potential trigger for its release.  Other than categorizing cortisol by one of the multiple 188 
factors the can cause its release, it would be better to categorize it by its downstream 189 
effects as a “metabolic” hormone.   Cortisol’s principal actions involve the stimulation of 190 
lipolysis to release fatty acids from adipose stores and the antagonism of 191 
gluconeogenesis, resulting in an increase in available oxidizable substrates (Widmaier 192 
et al., 2013).  Although cortisol is elevated as a consequence of short-term stresses, it 193 
rapidly returns to baseline when those stresses are removed.  Chronic energy 194 
demands, as can occur with infection and undernutrition (or, in other animals, migration 195 
and hibernation), can result in chronically elevated cortisol and a shift toward greater 196 
reliance on stored energy reserves. Shifts in chronic cortisol release also occur with 197 
reproductive state in human females, being elevated during pregnancy to mobilize 198 
maternal fat reserves to support fetal growth (Widmaier et al., 2013). 199 
 200 
 It should be noted that while cortisol promotes the release of free fatty acids via 201 
lipolysis, it does not stimulate the beta oxidation pathway by which fatty acids gain entry 202 
to the tricarboxylic acid cycle (Widmaier et al., 2013)  Pathological elevation of cortisol 203 
without increased energy expenditure, as in Cushing’s syndrome, can result in 204 
excessive fat accumulation in adipose depots and ectopic locations less sensitive to 205 
cortisol action and thus be associated with redistribution of fat rather than loss of fat 206 
(Despres and Lemieux, 2006). 207 
 208 
 In part because cortisol is readily measured in saliva and urine, as well as in 209 
blood, there are numerous field studies of human cortisol.  Many studies focus on short-210 
term cortisol dynamics in relation to psycho-social stress.  Field studies of longer term 211 
effects have focused on immune function, pregnancy, and lactation (Cohen et al., 2012; 212 
Janicki-Deverts et al., 2016; Nepomnaschy et al., 2006; Oaks et al., 2016; Valeggia and 213 
Ellison, 2004; Valeggia and Ellison, 2003). 214 
 215 
 b.  Efficiency of ATP production 216 
 217 
 At the cellular level the utilization of oxidizable substrates is auto-regulated by the 218 
accumulation of downstream products, and thus ultimately driven by energy 219 
expenditure.  However, basal metabolic rate, the baseline turnover of energy substrates 220 
in the body, is itself subject to hormonal regulation.  Among the most potent regulators 221 
of basal metabolism are the thyroid hormones, especially thyroxine (T4).  Under 222 
conditions of chronic energetic stress, such as fasting and starvation, T4 is lowered, 223 
resulting in a lower baseline rate of energy consumption by the body (McAninch and 224 
Bianco, 2014).  225 
 226 
 Up-regulation of T4 production can be part of an adaptive response to cold stress 227 
(Leonard et al., 2005; Leppaluoto et al., 2005).   The efficiency of ATP production by the 228 
mitochondrial electron transport chain in some tissues, particularly brown fat, is 229 
regulated by T4 through the up-regulation of uncoupling protein (UCP) (Busiello et al., 230 
2015; Leppaluoto et al., 2005).  UCP decouples the return flow of hydrogen ions across 231 
the mitochondrial inner membrane from ATP production, resulting in an increased 232 
production of heat.  UCP is particularly abundant in brown adipose tissue which can 233 
assist in the regulation of core body temperature, particularly in infants.  Field studies of 234 
high latitude populations have also demonstrated seasonal shifts in T4 production and 235 
basal metabolism in adults associated with recurrent cold stress, a response that 236 
appears to be greater in populations native to high latitudes than to more recent 237 
migrants (Leonard et al., 2014; Levy et al., 2013; Tkachev et al., 1991).  238 
 239 
 240 
Insulin-independent maintenance effort 241 
 242 
 Energy allocation is organized hierarchically.  Wade and Jones (Wade and 243 
Jones, 2004) schematically represent this hierarchy in three levels: functions that must 244 
be maintained at or near normal levels at all times; functions that can be down-245 
regulated at need, but cannot easily be interrupted for long periods; and functions that 246 
can be interrupted at need for extended periods.  The top priority functions include the 247 
maintenance of brain function via the constant maintenance of membrane 248 
depolarization as well as indispensable vegetal activities such as heart and respiratory 249 
function, and some aspects of kidney and liver function.  Mid-level priority functions 250 
include physical activity, immune function, and protein anabolism.  Dispensable or 251 
interruptible functions include growth and reproduction, although these are also subject 252 
to mid-level down-regulation as well as interruption. 253 
 254 
 Reproductive state can reorganize this hierarchy somewhat in females.  During 255 
pregnancy and lactation fetal growth and infant nutrition assume relatively high 256 
priorities, at or near the top level.  The interruption of female fecundity by pregnancy 257 
and early lactation can be viewed as evidence of the priority of the fetus and infant over 258 
lower level maternal priorities.  The down-regulation of maternal basal metabolism that 259 
can occur during pregnancy and lactation when energy availability is limited, noted 260 
above, can be seen as evidence of the higher metabolic priority assigned to the fetus 261 
and infant than mid-level priorities of the mother.   262 
 263 
 Top-level metabolic priorities are largely insulin-independent (Fernandez-Real 264 
and Ricart, 2003).  The brain and fetus are particularly clear examples of insulin-265 
independent substrate uptake.  Energy flow to these priorities is regulated only by the 266 
availability of oxidizable substrates in the blood.  The role of cortisol, glucagon, and 267 
epinephrine can be best understood as buffering energy flow to top-level functions.  268 
That is, when energy demands increase at lower levels, such as those precipitated by 269 
“fight or flight” scenarios, these hormones increase the levels of oxidizable substrates in 270 
the blood so that the new demands can be met without compromising top-level 271 
functions. Down-regulation of competing demands for oxidizable substrates can also 272 
increase their availability for top level functions.  Physiological responses to fasting and 273 
starvation, for example, include down-regulation of mid-level and low-level functions to 274 
free up energy for the top priority functions (Keys et al., 1950).  275 
 276 
Energy allocation to storage and anabolic effort 277 
 278 
 In textbooks the role of insulin at the organismic level is most often presented in 279 
terms of glucose homeostasis, its function being to stimulate the clearance of excess 280 
circulating glucose (Widmaier et al., 2013).  But this is a poor and incomplete 281 
characterization of its function.  Insulin does not simply facilitate removal of glucose 282 
from the blood, a function also performed by the kidney.  It stimulates the uptake of 283 
glucose by target tissues especially for storage in adipose tissue and to support protein 284 
anabolism.  Insulin also stimulates mitotic activity in many target tissues which, in 285 
conjunction with its anabolic effects, can promote cellular proliferation and tissue growth 286 
(Sandow, 2009). 287 
 288 
 Viewed in these terms, the key role of insulin is to promote energy allocation to 289 
medium and low priority metabolic functions on a facultative basis, not simply the 290 
regulation of circulating glucose levels.  When metabolic energy is available in excess of 291 
high and mid-level category requirements, insulin promotes the diversion of the excess 292 
either to storage or to anabolism.  Similarly, the “counter-regulatory hormones” cortisol, 293 
glucagon, and epinephrine, do not simply counter-balance the effects of insulin on blood 294 
glucose, but buffer the flow of energy to top-level metabolic functions from fluctuations 295 
in intake and lower level demands independently of insulin.  The balance of these 296 
hormones results in the hierarchical regulation of energy flow within the body, not simply 297 
in the avoidance of the pathological consequences of hyperglycemia. 298 
 299 
 Insulin was one of the first protein hormones to be isolated, characterized, and 300 
used therapeutically, due to its clinical importance in the pathogenesis and treatment of 301 
diabetes mellitus (Sanger and Tuppy, 1951a, b).  In this context, a great deal is known 302 
about short-term insulin dynamics in relation to changes in blood glucose.  But recently 303 
a new approach, based on measurement of C-peptide of insulin in urine, has been 304 
utilized to study longer-term changes in baseline insulin levels under field conditions 305 
and not in the context of disease (Sherry and Ellison, 2007).  C-peptide of insulin is a 306 
section of the pro-insulin molecule that is cleaved in the production of active insulin.  It is 307 
produced in a 1:1 ratio to active insulin and is cleared intact into the urine.  Thus 308 
measurement of urinary C-peptide, indexed by time, creatinine, or specific gravity, can 309 
be used as a proxy measurement of insulin production.  Urinary C-peptide measured in 310 
samples collected in the field has been used to study longitudinal and cross-sectional 311 
variation in energy balance in Samoa (Sherry and Ellison, 2007; Sherry et al., 2014), 312 
Argentina (Ellison and Valeggia, 2003; Valeggia and Ellison, 2001, 2004; Valeggia and 313 
Ellison, 2003), and The Gambia (Reiches et al., 2013; Reiches et al., 2014), among 314 
other settings. 315 
 316 
 317 
Biasing of energy allocation towards growth effort 318 
 319 
 Insulin controls energy allocation to lower priority metabolic categories, including 320 
energy storage, and the anabolic categories growth and reproduction.  The triage of 321 
energy allocation among these competing categories, however, is largely under the 322 
control of a trio of phylogenetically related protein hormones: growth hormone (GH), 323 
prolactin (PRL), and human placental lactogen (hPL).  The genes for growth hormone 324 
and human placental lactogen are both located on chromosome 17 and display ~96% 325 
sequence homology, indicating common ancestry through a gene duplication event.  326 
PRL is more distantly related, located on chromosome 6 and displaying ~ 85% 327 
sequence homology with GH.  GH and PRL are both synthesized and secreted by 328 
acidophilic cells of the anterior pituitary, while the hPL gene is expressed in the 329 
placenta.  All three hormones have suppressive effects on whole body insulin 330 
sensitivity, primarily through an inhibition of glucose uptake by somatic adipose tissue.  331 
At the same time, however, all three synergize with insulin in promoting anabolic 332 
processes in target tissues: accumulation of skeletal and lean body mass in the case of 333 
GH, mammary gland glucose uptake and milk synthesis in the case of PRL, and fetal 334 
glucose transfer and fetal growth in the case of hPL (Forsyth and Wallis, 2002; Goffin et 335 
al., 1996; Wallis et al., 2005).   336 
 337 
 The secretion of these hormones varies with maturational and reproductive 338 
status, resulting in the differential allocation of available metabolic energy among these 339 
anabolic categories.  GH follows a steep decline following birth as the high rate of infant 340 
growth declines to low levels in mid-childhood, but it undergoes an endogenous rise in 341 
puberty, serving to promote skeletal and lean body growth (Bona et al., 1999; Rose et 342 
al., 1991).  At the same time, by increasing insulin resistance in adipose tissue it limits 343 
energy allocation to storage and causes a transient rise in basal insulin levels (Guercio 344 
et al., 2002).  hPL by the placenta increases through pregnancy, elevating insulin 345 
resistance in the mother and increasing the flow of metabolic energy to the fetus 346 
(Braunstein, 2003; Mesiano and Jaffe, 2004).  PRL production during lactation is 347 
stimulated by infant nursing demand and acts to promote the uptake of glucose and 348 
fatty acids by the mammary gland and the production of milk.  At the same time it 349 
increases insulin resistance in maternal adipose tissue, resulting in a diversion of 350 
metabolic energy to milk production (Molitch, 2004). 351 
 352 
 There is a long history of measuring prolactin in field studies of lactation (see 353 
(Ellison, 1995) and growth hormone in studies of human growth (see Bogin, 1999).  354 
Studies of hPL are confined to clinical settings. 355 
 356 
 357 
Energy allocation to reproductive effort 358 
 359 
 Energy allocation to reproductive effort is primarily reflected and governed by 360 
gonadal steroids (Ellison, 2003b).  In females, ovarian steroids directly modulate 361 
fecundity, influence sexual attractiveness to males as well as receptive and proceptive 362 
sexual behavior, and promote energy storage in adipose tissue (an important form of 363 
somatic reproductive effort in females).  In males, testosterone maintains sperm 364 
production, stimulates libido and mating effort and may also support increased social 365 
confidence and assertiveness, and promotes increases in muscle mass (an important 366 
form of somatic reproductive effort in males). 367 
 368 
 The production and release of gonadal steroids is governed by the gonadotropin 369 
hormones, follicle stimulating hormone (FSH) and luteinizing hormone (LH) secreted by 370 
the anterior pituitary.  However, the effectiveness of this gonadotropin stimulation 371 
depends strongly on insulin, so strongly that insulin is sometimes characterized as a co-372 
gonadotropin (Poretsky et al., 1999; Poretsky and Kalin, 1987).  This effect has been 373 
mostly clearly demonstrated in in vitro studies of steroid production by cultured ovarian 374 
granulose cells, where insulin receptor has been identified as the mediator of the effect, 375 
increasing the rate of steroid production per cell. 376 
 377 
 Gonadal steroids, in their turn, synergize with insulin in promoting somatic 378 
reproductive effort in both sexes, promoting increases in muscle mass in males 379 
(androgens) and increases in adipose mass in females (estrogens) (Grumbach and 380 
Styne, 2003).  The mutual synergies between insulin and gonadal steroids constitute a 381 
positive feedback loop that can dramatically up-regulate the flow of metabolic energy to 382 
reproductive effort to take advantage of conditions of positive energy balance and the 383 
availability of metabolic energy in excess of the needs of high priority categories. 384 
 385 
 The advent of practical methods for assaying gonadal steroids in saliva (Ellison, 386 
1988; Lipson and Ellison, 1989), in addition to blood and urine, led to a rapid increase in 387 
the number of field studies of gonadal steroids in human populations.  Many examples 388 
are provided elsewhere in this issue.  389 
 390 
Hormonal gating of energy allocation 391 
 392 
 The hormonal framework described above governs the allocation of available 393 
metabolic energy to competing domains in a hierarchical way.  Top priority metabolic 394 
categories, including brain and vegetal physiology, as well as fetal growth and infant 395 
nutrition during pregnancy and lactation, receive energy in direct proportion to its 396 
availability.  That availability is determined by the hormones that mobilize oxidizable 397 
substrates and those that govern the rate and efficiency of ATP production as well as by 398 
the competing demands of physical activity. 399 
 400 
 Insulin controls the gate for allocation of energy to lower level, “dispensable” 401 
categories such as energy storage, growth, and reproduction.  Cortisol opposes this 402 
allocation, increasing the availability of metabolic energy to mid-level categories such as 403 
immune function as well as buffering top level allocations.  Allocation of metabolic 404 
energy among potentially competing lower level categories is governed by GH, PRL, 405 
hPL, and gonadal steroids interacting with and modifying the action of insulin. 406 
 407 
 The dynamic interaction of the key hormones governing energy allocation helps 408 
to organize key life history transitions.  Puberty and postpartum resumption of ovarian 409 
function are two particularly clear examples and will be considered here in some detail. 410 
 411 
The pubertal transition 412 
 413 
 Puberty involves a transition in energy allocation from growth to adult 414 
reproductive potential during which the body is modified, sexual dimorphism is 415 
elaborated, and reproductive potential is established (Ellison et al., 2012).  Although not 416 
as dramatic as the metamorphosis of holometabolous insects or most amphibians, it is 417 
the human equivalent, changing juvenile morphology to a distinctively adult pattern and 418 
elaborating immature, nonfunctional reproductive organs into mature, functioning ones.  419 
Puberty involves the close coordination of primary reproductive maturation with the 420 
rapid growth and transformation of the body.  Reproductive maturation involves the 421 
appearance (or, more properly, reappearance) of pulsatile release of gonadotropin 422 
releasing-hormone (GnRH) by the median eminence of the hypothalamus, which in turn 423 
stimulates increased production of FSH and LH (Grumbach and Styne, 2003).  The 424 
factors that determine this change in GnRH production are still incompletely understood, 425 
but the change begins quite early, well before internal or external manifestations of 426 
increasing gonadal activity.  The skeletal growth spurt that is typical of puberty is 427 
primarily caused by an endogenous increase in GH and its downstream consequences 428 
(Grumbach and Styne, 2003).  Again, the causes of the increase in GH secretion are 429 
incompletely understood, but its timing is roughly synchronous with the first appearance 430 
of pulsatile gonadotropin secretion, suggesting a linkage between the two events (Suter, 431 
2004; Gahete et al., 2016).  The elaboration of somatic sexual dimorphism results from 432 
the interaction of pubertal growth with rising titers of gonadal steroids.  Differential 433 
growth between the sexes resulting in adult sexual dimorphism is mediated by gonadal 434 
steroids, both androgens and estrogens (Ellison et al., 2012). 435 
 436 
 The hormonal management of energy allocation during the pubertal transition 437 
can be sketched out in terms of the framework described above.  We assume that the 438 
process is set in train when pulsatile GnRH reappears and GH begins to rise, even if the 439 
direct causes of those two events remain to be fully understood.  Rising levels of GH 440 
stimulate growth and divert energy away from storage.  The elevated GH also results in 441 
increasing insulin resistance in adipose tissue, causing basal levels of insulin to rise.  442 
Rising insulin would synergize with the increasing gonadotropin titers resulting from 443 
increasingly stable GnRH pulses to promote gonadal steroid production and release.  444 
As they approach mature levels, gonadal steroids in turn will potentiate the peripheral 445 
effects of insulin, leading to a shift back toward lower insulin levels and increased 446 
energy allocation to fat storage (in females) and muscle mass (in males), now as 447 
sexually dimorphic forms of somatic reproductive effort.  Even as they shift the direction 448 
of energy allocation, gonadal steroids cause the closure of epiphyseal growth plates 449 
and the cessation of skeletal growth as well as causing the remodeling of the female 450 
pelvis.   451 
 452 
 In this way the pubertal transition unfolds as an endogenous process governed 453 
by the interaction of the endocrine framework of energy allocation and its integration 454 
with the growth and maturational processes involved.  Energy allocation is first diverted 455 
away from storage to support somatic growth and transformation and then returned to 456 
storage as well as sexually dimorphic somatic forms of reproductive effort.  A 457 
characteristic and transient period of hyperinsulinemia is a central part of the process, 458 
helping to accelerate gonadal steroid production to its mature levels.  The mature 459 
steroid levels in turn resolve the transient insulin resistance. 460 
 461 
 This schema is consistent with observations of shifting energy allocation priorities 462 
in female Gambian adolescents (Reiches et al., 2014).   In the midst of the pubertal 463 
transition, when skeletal growth is still underway, Gambian girls will respond to periods 464 
of energetic stress by defending lean body mass at the expense of fat mass, but later in 465 
the process as skeletal growth comes to a halt the same periods of energetic stress are 466 
associated with a defense of fat mass at the expense of lean body mass.  The 467 
metabolic priority given to growth early gives way to a metabolic priority of somatic 468 
reproductive effort late (Figure 3). 469 
 470 
A mathematical model of the pubertal transition 471 
 472 
 The smooth, autonomous nature of the transition can also be demonstrated in a 473 
quantitative model of female puberty.  The specifics of the model are provided in 474 
Supplementary Materials.  The point of the model is to demonstrate that the interactions 475 
between the principal hormonal regulators reviewed above act like interlocking gears, 476 
so that changes in one component drive changes in the system as a whole.  The shape 477 
of the changes that ensue is a function of the feedback links within the system.  The 478 
central set of interactions are those between insulin directing energy to anabolic effort, 479 
the pituitary proteins (prolactin, growth hormone, placental lactogen) biasing energy to 480 
growth effort and feeding back on insulin through their effects on somatic insulin 481 
resistance, and the gonadal steroids (estradiol, progesterone, and testosterone) biasing 482 
energy to reproductive effort and feeding back negatively on the pituitary proteins 483 
regulating growth effort.  Because the interactions of these hormones are interlocking, 484 
the system as a whole can be changed by changes in any one of the components.  But 485 
the nature of the interactions causes the system to “switch” from a bias toward growth 486 
effort to a bias toward reproductive effort, a switch that reflects the essential nature of a 487 
life history transition as defined in this paper.  Both the transition from growth to 488 
reproduction at puberty (described here) and the resumption of ovarian function 489 
postpartum (described below) can be modeled by the same system of interactions. 490 
 491 
The assumptions and parameter settings of the quantitative models are meant to 492 
be as simple as possible.  In the model of the pubertal transition, GH is assumed to be 493 
the independent driving factor, with all other variables dependent on it.  In fact, the 494 
initiation of the GH rise remains something of a mystery.  There is mounting evidence 495 
suggesting that the rise in GH may be tied to the same neural mechanisms, including 496 
kisspeptin signaling to the pituitary, that disinhibit GnRH pulsatility in the hypothalamus 497 
(Gahete et al., 2016).  This would suggest that the initiation of the GH rise and the 498 
nocturnal, sleep-associated appearance of pulsatile LH may be more or less coincident 499 
(Apter, 1997, Suter 2004).  In any event, increases in GH ordinarily precede detectable 500 
increases in gonadal steroids (Rogol, 2010).  So in this model the assumption is made 501 
that a rise in GH starts the transition. 502 
 503 
GH is assumed to fall steeply with age prior to puberty in parallel with growth 504 
velocity (Bona et al., 1999; Rose et al., 1991; Chemaitilly et al., 2003), according to a 505 
rational function (a simple mathematical expression for a pattern of smooth, asymptotic 506 
decline (Otto and Day, 2007), with an endogenous, normally shaped rise and fall 507 
beginning at about age 8 years and centered on age 12.5 years.  These ages are 508 
arbitrary, but are chosen to reflect contemporary observations of adolescent growth for 509 
females in the US and other developed nations where high quality longitudinal data are 510 
available (Kuczmarski et al., 2002).  For males, the age parameters can be set 511 
approximately two years later.  The normal shape of the GH rise during puberty is an 512 
arbitrary assumption that generally reflects the observed pattern (Albertsson-Wikland et 513 
al., 1994).  The exact shape of the trajectory isn’t important to the model; what is 514 
important is that GH undergoes a rise at puberty before falling to adult levels. 515 
 516 
  Insulin, independent of the effect of GH, is assumed to follow a slow logistic rise 517 
from childhood to adult levels (Ballerini et al., 2016).   However, the effect of GH on 518 
insulin resistance, assumed to be proportional to the level of GH, results in a transient 519 
increase in insulin.  Estradiol, in the absence of insulin, is assumed to follow a slow 520 
logistic rise to adult levels, becoming noticeable (about 10% of adult levels) at about the 521 
same time as the start of the GH rise, driven by gonadotropin levels that are themselves 522 
responding to the resumption of pulsatile GnRH release.  The logistic form of the 523 
estradiol trajectory is arbitrary but is a simple mathematical form that can be used to 524 
model sigmoid patterns (Otto and Day, 2007).  A dummy factor (“lag” ) is introduced to 525 
center the inflection point of the estradiol at about 12.5 years (around the time of 526 
menarche) and an asymptotic approach to adult levels at around 20 years.  This pattern 527 
reflects empirical observations indicating continued increases in ovarian function for a 528 
number of years after menarche until at least the late teens/early twenties (Lipson and 529 
Ellison 1992, Ellison 1996).  Under the stimulating influence of insulin, assumed to be 530 
proportional to insulin level, the rise in estradiol becomes steeper and overshoots final 531 
adult levels slightly before converging on them in the late teens.  Growth rate is 532 
assumed to be proportional to GH levels, minus a braking effect assumed to be 533 
proportional to estradiol levels, resulting from the action of estradiol in accelerating the 534 
closure of the epiphyses of the long bones.  The breaking effect of estradiol results in a 535 
more rapid deceleration of growth that reaches its steepest decline at about the time of 536 
menarche.  The resulting pattern is represented in Figure 4.  As noted above, the 537 
parameters have been arbitrarily set to reflect the timing of puberty similar to that in the 538 
US and other industrialized populations.  Delay in the initial rise in GH would shift the 539 
entire pattern to the right, typical of later puberty.  Substitution of testosterone for 540 
estradiol, together with a later onset of the GH rise, would generate a model typical of 541 
males.  Note that testosterone conversion to estradiol in the growth plates results in the 542 
same breaking effect on linear growth as in females.  Note also that the model does not 543 
specify exact hormone levels, but only relative levels, with 1.0 representing typical adult 544 
values. 545 
 546 
The postpartum resumption of ovarian function 547 
 548 
 A second example of the hormonal orchestration of a life history transition is the 549 
postpartum resumption of ovarian function.  In this case, a transition occurs between 550 
energetic allocation to milk and energetic investment in fecund reproductive capacity.  551 
The transition unfolds in a manner very reminiscent of the pubertal transition, with PRL 552 
taking on the role played by GH during puberty.  In a lactating mother early in the 553 
postpartum period milk production assumes a high priority.  It is driven by PRL secretion 554 
which is responsive to infant demand but also reflective of maternal energy availability 555 
(Ellison, 1995).  When infants are exclusively breastfed by mothers facing energetic 556 
constraints, PRL levels will be high and insulin levels low.  PRL directs energy toward 557 
milk production by increasing the insulin resistance of peripheral maternal adipose 558 
tissue (though there is also evidence that PRL increases insulin sensitivity in mammary 559 
adipose tissue).  Gonadal activity is extremely low, though FSH levels are near normal 560 
(McNeilly et al., 1994), suggesting ovarian resistance to gonadotropin stimulation. 561 
 562 
 Later in the postpartum period PRL levels begin to decline.  This occurs most 563 
often as a consequence of the introduction of supplementary foods into the infant’s diet 564 
(McNeilly et al., 1994), reducing the demand for milk.  Reduced energy demand for milk 565 
production results in increased energy availability to the mother and rising levels of 566 
basal insulin.  Energy allocation to storage rises as a consequence, but PRL levels 567 
remain sufficient to cause elevated insulin resistance.  As a result, insulin levels rise 568 
above the typical level for the mother, manifesting a brief, transient period of 569 
hyperinsulinemia.  This transient period of hyperinsulinemia, although briefer in 570 
duration, is very reminiscent of the transient period of elevated insulin in puberty.  The 571 
elevated insulin synergize with FSH levels to stimulate ovarian steroid production 572 
toward normal mature levels.  The rising titers of estradiol that result in turn potentiate 573 
energy storage in adipose tissue, increasing adipose insulin sensitivity and returning 574 
insulin levels to normal. 575 
 576 
 As with the pubertal transition, the resumption of postpartum ovarian function is 577 
governed endogenously by the endocrine architecture of energy allocation.  Insulin once 578 
again plays a central role, modified by the actions of PRL and gonadal steroids.  The 579 
unfolding sequence is clearly displayed by Toba mothers in Argentina (Ellison and 580 
Valeggia, 2003; Valeggia and Ellison, 2001, 2004; Valeggia and Ellison, 2003) (Figure 581 
5), and a comparable pattern has even been observed in wild chimpanzees in Uganda 582 
(Emery Thompson et al., 2012).  583 
 584 
A mathematical model of the postpartum resumption of ovarian function 585 
 586 
 As with the pubertal transition, the smooth, endogenous nature of the resumption 587 
of ovarian function postpartum can be represented in a qualitative model (details in 588 
Supplementary Materials).  This model includes analogous hormonal interactions to 589 
those presented in the puberty model above.  In this case, PRL level is assumed to be 590 
the independent driving factor with other variables being dependent on it.  Prolactin is 591 
assumed to decline following a logistic function (a simple expression for a sigmoid 592 
pattern, Otto and Day, 2007) and to represent the energy demand for milk production.  593 
In the version of the model presented here the decline in PRL is parameterized to return 594 
to baseline by 40 months with a maximal rate of decline at 18-20 months.  This is an 595 
arbitrary parameterization designed to reflect patterns observed in the Toba (Valeggia 596 
and Ellison, 2004).  Different values for the parameters of the logistic could be chosen 597 
to reflect earlier or later weaning or other factors affecting energy availability.  Energy 598 
availability for lower level priorities than milk production is assumed to be proportional to 599 
the complement of PRL (where peak PRL is set at 1.0 as a reference).  Insulin is 600 
expected to be proportional to energy availability, but modified by the insulin resistance 601 
caused by prolactin.  If insulin sensitivity were constant, insulin levels would rise 602 
proportionally to energy availability.  However, due to the declining effect of prolactin on 603 
insulin resistance, insulin rises more steeply and overshoots typical “post lactation” 604 
levels (set at 1.0).  Estradiol levels rise proportionally to insulin with a slight, arbitrary lag 605 
time, while postpartum weight gain is proportional to the product of energy availability 606 
and insulin.  The resulting pattern is represented in Figure 6 with parameters adjusted to 607 
be roughly equivalent to observations made on the Toba.  Once again, variable values 608 
are relative with 1.0 representing adult, non-lactating values of all variables except PRL, 609 
where 1.0 represents peak values early in lactation. 610 
 611 
 The heuristic value of the mathematical model is to make explicit the fact that the 612 
mutual interactions of a core set of hormones regulating energy allocation, interactions 613 
that are well-established in the literature, are sufficient to generate the rather complex 614 
trajectories of hormones and anabolic variables (e.g., growth rate, milk production, 615 
weight gain) that are observed during two important life history transitions, puberty and 616 
the post-partum resumption of ovarian function.  It is not necessary to assume any 617 
special set of interactions or drivers to generate these patterns.  Rather the “switch” 618 
from growth effort to reproductive effort is latently embedded in the effect these 619 
important regulators have on each other.  Natural selection has been able to leverage 620 
the same endocrine architecture to orchestrate two different life history transitions by 621 
making use of two different, but phylogenetically related, modifiers of anabolic energy 622 
allocation, GH and PRL.  Although beyond the scope of this paper, it can be argued that 623 
this architecture has analogues in other vertebrates (Chandrashekar and Bartke, 2003, 624 
Kawashima et al., 2007, Flatt and Heyland, 2011). 625 
 626 
 627 
Concluding comments 628 
 629 
 The model framework presented here is just that: a model that represents only a 630 
few of the major features of a complex network or interacting signals that govern human 631 
energetic allocation.  Its heuristic value is illustrated in its ability to capture the major 632 
signals and interactions in sufficient detail to illuminate the dynamic aspects of the 633 
control of energy allocation during major life history transitions.  In doing so, it helps to 634 
connect our knowledge of the mechanisms that govern energy allocation with the 635 
predictions and tradeoffs that feature in life history theory.  As a major branch of 636 
evolutionary theory, life history theory has proven very powerful in predicting and 637 
explaining major features of life history diversity, and in doing so it leans very heavily on 638 
generalized concepts of energetic tradeoffs.  But less effort has been made to integrate 639 
life history theory with proximate mechanisms until recently (Flatt and Heyland, 2011).   640 
 641 
 The model presented here also underscores the central role of insulin, not as a 642 
gluco-regulatory hormone, but as the major gatekeeper of energy allocation to mid- and 643 
lower level physiological priorities.  Insulin does not simple clear glucose from the 644 
circulation to guard against negative effects of hyperglycemia, it directs energy toward 645 
growth and reproductive effort, synchronizing investment in those physiological 646 
categories with the availability of metabolic energy over and above the requirements of 647 
higher priority categories.  This centrality of insulin in the modulation of energy 648 
allocation helps to make sense of the phylogenetically highly conserved relationship 649 
between insulin and insulin-like signaling and lifespan variation (Barbieri et al., 2003; 650 
Singleton, 2011; Tatar et al., 2003).  Insulin is one of the best known and longest 651 
studied human hormones.  It may not have the cachet of more recently identified 652 
neuropeptides and cytokines, nor does it represent control of the soma by the CNS.  Yet 653 
its role in life history energetics is crucial. 654 
 655 
 Finally, although developed in the context of human physiology, there is reason 656 
to suspect that the framework presented here may have more general application, 657 
either directly or as a template to modify and build on.  The comparability of the 658 
trajectory of C-peptide of insulin in relation to the postpartum resumption of ovarian 659 
function in humans and chimpanzees is one example that supports this notion.  The 660 
framework developed and presented here may serve as an impetus for comparative 661 
studies of the hormonal architecture of energy allocation in non-human primates and 662 
mammals generally.   663 
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Figure Captions 896 
 897 
 898 
Figure 1:  The basic framework of energy flow underlying human life history energetics.  899 
Numbers associated with the arrows refer to the groups of hormonal regulators 900 
specified in Figure 2.  The parenthetical number associated with energy flow from 901 
available metabolic energy to activity indicates potentially weak or indirect hormonal 902 
regulation. 903 
 904 
 905 
Figure 2:  Categories of hormonal regulators associated with the pathways of energy 906 
flow specified in Figure 1.  Examples of major hormonal regulators in each category are 907 
given and further elaborated upon in the text. 908 
 909 
 910 
Figure 3:  Body composition changes (means ± SE) in adolescent females in The 911 
Gambia during periods of relative energy abundance (harvest season) and energy 912 
constraint (hungry season) subdivided by growth rate.  Details provided in Reiches et al. 913 
2014. 914 
 915 
 916 
Figure 4:  Trajectories of growth hormone, growth rate, estradiol, and insulin during 917 
puberty generated by a simple model of the basic framework of human life history 918 
energetics presented in this paper and illustrated in Figure 1.  The Y-axis units are 919 
expressed in proportion to adult values for each variable.  Details of the model are 920 
provided in Supplementary Materials. 921 
 922 
 923 
Figure 5:  Plots of first morning urinary C-peptide of insulin levels expressed as a 924 
proportion of individual, post-resumption average levels for each individual during the 925 
postpartum lactation period as observed among Toba women compared with the 926 
trajectories of (A) BMI and (B) urinary estrone conjugates (urinary metabolite of 927 
estradiol).  Compare these trajectories with those generated by the model depicted in 928 
Figure 5.  Data from Ellison and Valeggia 2003, Valeggia and Ellison 2001, 2003, 2004. 929 
 930 
 931 
Figure 6:  Trajectories of insulin, estradiol, postpartum weight gain, energy availability, 932 
and prolactin during the postpartum lactating period generated by a simple model of the 933 
basic framework of human life history energetics presented in this paper and illustrated 934 
in Figure 1.  The Y-axis units are expressed in proportion to adult values for each 935 
variable.  Details of the model are provided in Supplementary Materials. 936 
 937 
 938 
 939 
